Reynders McVeigh Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,356
Closed -$412K 205
2018
Q2
$412K Sell
10,356
-90,140
-90% -$3.47M 0.05% 147
2018
Q1
$3.75M Sell
100,496
-39,840
-28% -$1.61M 0.47% 43
2017
Q4
$6M Sell
140,336
-41,788
-23% -$1.67M 0.79% 34
2017
Q3
$6.68M Sell
182,124
-4,950
-3% -$200K 0.87% 35
2017
Q2
$8.49M Buy
187,074
+4,385
+2% +$194K 1.14% 28
2017
Q1
$7.77M Buy
182,689
+14,285
+8% +$582K 1.07% 28
2016
Q4
$6.76M Buy
168,404
+17,095
+11% +$660K 0.96% 30
2016
Q3
$5.88M Buy
151,309
+6,448
+4% +$243K 0.86% 33
2016
Q2
$5.01M Buy
144,861
+55,808
+63% +$1.93M 0.73% 37
2016
Q1
$3.07M Buy
89,053
+74,454
+510% +$2.6M 0.45% 45
2015
Q4
$565K Buy
+14,599
New +$568K 0.09% 117

Other funds holding HOLX

Reynders McVeigh Capital Management's HOLX Position: Q3 2018 in Review

Reynders McVeigh Capital Management sold out of Hologic (HOLX) in Q3 2018, closing a stake of 10,356 shares — an estimated $412K sold.

Reynders McVeigh Capital Management first reported a position in HOLX in Q4 2015 and held it in 11 quarters. The position peaked at $8.49M in Q2 2017. 446 funds tracked by Wall St. Rank hold HOLX as of Q3 2018.

  • Reynders McVeigh Capital Management reported no remaining Hologic position as of Q3 2018 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 10,356 Hologic shares in Q3 2018, an estimated $412K.
  • Reynders McVeigh Capital Management first reported a position in Hologic in Q4 2015 and held it in 11 quarters.
  • Reynders McVeigh Capital Management's Hologic position peaked at $8.49M in Q2 2017.
  • 446 funds tracked by Wall St. Rank held Hologic as of Q3 2018.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2018, filed 20 Nov 2018.